CNBX Pharmaceuticals (CNBX) Invested Capital (2016 - 2025)
CNBX Pharmaceuticals (CNBX) has disclosed Invested Capital for 14 consecutive years, with -$2.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital fell 2.33% year-over-year to -$2.6 million, compared with a TTM value of -$2.6 million through Nov 2025, down 2.33%, and an annual FY2025 reading of -$2.5 million, down 110.68% over the prior year.
- Invested Capital was -$2.6 million for Q4 2025 at CNBX Pharmaceuticals, down from -$2.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $4.5 million in Q1 2021 and bottomed at -$2.6 million in Q4 2025.
- Average Invested Capital over 5 years is -$287157.2, with a median of -$625285.0 recorded in 2023.
- The sharpest move saw Invested Capital soared 51.76% in 2021, then tumbled 892.63% in 2023.
- Year by year, Invested Capital stood at $1.9 million in 2021, then tumbled by 111.28% to -$211049.0 in 2022, then crashed by 892.63% to -$2.1 million in 2023, then decreased by 20.02% to -$2.5 million in 2024, then decreased by 2.33% to -$2.6 million in 2025.
- Business Quant data shows Invested Capital for CNBX at -$2.6 million in Q4 2025, -$2.5 million in Q3 2025, and -$2.5 million in Q2 2025.